Şunu aradınız:: ivabradin (Hırvatça - İngilizce)

corlentor ivabradin
corlentor ivabradine

ivabradin je indiciran:
ivabradine is indicated :

ivabradine anpharm ivabradin
ivabradine anpharm ivabradine

ivabradin (n=3241) n (%)
ivabradine (n=3241) n (%)

ivabradin utječe na funkciju mrežnice.
ivabradine influences retinal function.

procoralan 5 mg filmom obložene tablete ivabradin
procoralan 5 mg film-coated tablets ivabradine

ivabradin ne utječe na sposobnost rada sa strojevima.
ivabradine has no influence on the ability to use machines.

corlentor je lijek koji sadrži djelatnu tvar ivabradin.
corlentor is a medicine that contains the active substance ivabradine.

ivabradine anpharm 5 mg filmom obložene tablete ivabradin
ivabradine anpharm 5 mg film-coated tablets ivabradine

ivabradin je primalo 74 bolesnika (omjer 2:1).
74 received ivabradine (ratio 2:1).

ivabradin je s-enantiomer, a biokonverzija nije demonstrirana in vivo.
ivabradine is the s-enantiomer with no bioconversion demonstrated in vivo.

ispitivanja na životinjama ukazuju da se ivabradin izlučuje u majčino mlijeko.
animal studies indicate that ivabradine is excreted in milk.

ivabradin se ne preporučuje u bolesnika sa av-blokom 2. stupnja.
ivabradine is not recommended in patients with av-block of 2nd degree.

ivabradin se metabolizira jedino citokromom cyp3a4 i vrlo je slab inhibitor toga citokroma.
ivabradine is metabolised by cyp3a4 only and it is a very weak inhibitor of this cytochrome.

ivabradin je ispitan u kliničkim ispitivanjima u kojima je sudjelovalo gotovo 45 000 osoba.
ivabradine has been studied in clinical trials involving nearly 45,000 participants.

procoralan 5 mg filmom obložene tablete procoralan 7,5 mg filmom obložene tablete ivabradin
procoralan 5 mg film-coated tablets procoralan 7.5 mg film-coated tablets ivabradine

ivabradine anpharm (ivabradin) je lijek za srce koji se primjenjuje u liječenju:
ivabradine anpharm (ivabradine) is a heart medicine used to treat:

ishodi ovih procjena podupiru nepostojanje rizika ivabradina za okoliš pa shodno tome ivabradin ne predstavlja opasnost za okolinu.
outcomes of these evaluations support the lack of environmental risk of ivabradine and ivabradine does not pose a threat to the environment.

ivabradin može uzrokovati prolazne vidne poremećaje u obliku fosfena (vidjeti dio 4.8).
ivabradine may cause transient luminous phenomena consisting mainly of phosphenes (see section 4.8).

postoje ograničeni podaci o primjeni u bolesnika s blagom do umjerenom hipotenzijom te se ivabradin treba oprezno primjenjivati u tih bolesnika.
limited data are available in patients with mild to moderate hypotension, and ivabradine should therefore be used with caution in these patients.